Tiopronin

CHEMBL1314 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
163.2 g/mol
LogP
-0.1
Phase
4

Tiopronin (alpha-mercaptopropionylglycine) is a free thiol compound that forms mixed disulfide bonds with cysteine in urine, producing a more soluble cysteine-tiopronin complex that prevents cystine stone formation in patients with cystinuria by reducing free urinary cystine concentration below its saturation threshold. It is also used for the treatment of Wilson's disease as a copper-chelating agent and as a disease-modifying agent in rheumatoid arthritis. Its thiol group provides the chemical reactivity underlying all its clinical applications.

आणविक भार

163.2000 g/mol

LogP

-0.10

TPSA

67.40 Ų

लिपिंस्की RO5

उत्तीर्ण

क्रिया का तंत्र

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(S)C(=O)NCC(=O)O

InChI

InChI=1S/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8)

Molecular Formula

C5H9NO3S

HBD / HBA

3 / 4

घूर्णनीय बंधन

3

भारी परमाणु

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Tiopronin (alpha-mercaptopropionylglycine) is a free thiol compound that forms mixed disulfide bonds with cysteine in urine, producing a more soluble cysteine-tiopronin complex that prevents cystine stone formation in patients with cystinuria by reducing free urinary cystine concentration below its saturation threshold. It is also used for the treatment of Wilson's disease as a copper-chelating agent and as a disease-modifying agent in rheumatoid arthritis. Its thiol group provides the chemical reactivity underlying all its clinical applications.

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Yes, Tiopronin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1314. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5483. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.